Hemington Wealth Management Amneal Pharmaceuticals, Inc. Transaction History
Hemington Wealth Management
- $645 Million
- Q1 2025
A detailed history of Hemington Wealth Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 113 shares of AMRX stock, worth $847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 96
17.71%
Holding current value
$847
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$118 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$92.5 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$84.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$80.5 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$56.2 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.14B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...